688131.SS · 皓元医药
China A-shares · RS rating 88 · As of 2026-10-14
| Price | 87.51 CNY |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 88 / 70 / 58 / 79 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 48 / 46 / 32 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +26.2% |
| Distance from 52-week high | +20.7% |
| Market cap (USD) | $3.0B |